In some studies of early gastric neoplasm, HER2 is thought to be involved in the early steps of gastric carcinogenesis, and HER2 overexpression in gastric cancer is a predictor of poor survival18,23. This evidence concerns the gene ERBB2 and gastric neoplasm.